Internal Medicine, Endocrinology, Diabetes, & Metabolism · Laguna Hills, CA
NPI
1275631657
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
24422 Avenida de la Carlota Ste 375
Laguna Hills, CA, 92653
Phone (949) 770-4177
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$3.0M
8,037 prescriptions
Company payments, 2025
$5,243
From 40 companies
Medicare prescription drug claims, 2024
In 2024, the drug Alan Marcus prescribed most often to Medicare patients was Ozempic (Semaglutide), with 621 prescriptions and refills. In total Alan Marcus wrote 8,037 Medicare prescriptions that cost $3.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-14.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 621 | 719 | 96 | $633K |
| Rosuvastatin Calcium Generic | 419 | 1,156 | 133 | $7,125 |
| Ezetimibe Generic | 395 | 1,042 | 116 | $12K |
| Metformin Hcl Generic | 380 | 1,056 | 116 | $2,221 |
| Mounjaro Tirzepatide | 325 | 387 | 44 | $396K |
| Synthroid Levothyroxine Sodium | 297 | 750 | 81 | $30K |
| Levothyroxine Sodium Generic | 251 | 702 | 77 | $3,725 |
| Jardiance Empagliflozin | 248 | 563 | 65 | $317K |
| Repatha Sureclick Evolocumab | 155 | 251 | 34 | $143K |
| Atorvastatin Calcium Generic | 113 | 315 | 34 | $898 |
| Allopurinol Generic | 109 | 281 | 31 | $1,018 |
| Farxiga Dapagliflozin Propanediol | 106 | 218 | 25 | $123K |
| Amlodipine Besylate Generic | 92 | 226 | 22 | $755 |
| Gabapentin Generic | 90 | 210 | 28 | $2,243 |
| Metoprolol Succinate Generic | 87 | 225 | 25 | $1,085 |
Brand drugs: 2,888 claims; generic drugs: 5,038 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan Marcus $5,243 ($5,243 in general payments such as food, travel and fees) from 40 companies. The largest payer was Abbvie Inc. with $843.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 42 | $843 |
| Novo Nordisk Inc NVO | 34 | $781 |
| Aimmune Therapeutics, Inc. | 33 | $692 |
| Amgen Inc. AMGN | 18 | $301 |
| Lilly USA, LLC LLY | 15 | $297 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $191 |
| Xeris Pharmaceuticals, Inc. | 12 | $182 |
| Harmony Biosciences LLC HRMY | 2 | $170 |
| Mannkind Corporation MNKD | 17 | $154 |
| Esperion Therapeutics, Inc. ESPR | 7 | $142 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.